Recordati Industria Chimica e Farmaceutica S.p.A.
Stock Details
Is it expensive?
Market Cap
10.08B
Trailing P/E Ratio
22.48
Forward P/E Ratio
13.37
PEG Ratio
0.95
12.31B
12.47
Price-to-Sales (TTM)
3.90
5.02
10.13
Is it profitable?
2.65B
Net Profit Margin (TTM)
17.79%
Gross Profit Margin
71.60%
Diluted EPS (TTM)
2.26
23.36%
Is it growing?
4.90%
22.40%
Is it risky?
0.52
115.13
2.37B
1.26
Who owns it?
32.15%
46.80%
0.00%
203.43M
107.50M
Does it pay?
2.80%
57.65%
May 18, 2026
--
How much cash?
380.47M
534.98M
536.78M
1.87
- Price (EOD)
- 51.30
- Percent Change
- +0.15 (0.29%)
- Previous Close
- 51.15
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€51.30
From 52W Low
--
From 52W High
--
Today
+0.29%
1Y Change
--
Today
€51.30
From 52W Low
--
From 52W High
--
Today
+0.29%
1Y Change
--
Today
€51.30
Fairly Priced
within its 1-year price range
€51.30
Rate of Change (ROC)
Insufficient price history
- Name
- Recordati Industria Chimica e Farmaceutica S.p.A.
- Founded
- 1926
- CEO
- Robert Koremans
- Employees
- 4,700
- Fiscal Year End
- Dec 31, 2025
- Address
Via Matteo Civitali,1
Milan
MI
20148
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- recordati.com
Indicators
Operating Cash Flow
534.98M
Net Income
471.64M
Backed by Cash
1.13
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
FTSE MIBIndex FTSE MIB - FTSEMIB |
Indicators
Operating Cash Flow
534.98M
Net Income
471.64M
Backed by Cash
1.13
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
10.08B
Trailing P/E Ratio
22.48
Forward P/E Ratio
13.37
PEG Ratio
0.95
12.31B
12.47
Price-to-Sales (TTM)
3.90
5.02
10.13
Is it profitable?
2.65B
Net Profit Margin (TTM)
17.79%
Gross Profit Margin
71.60%
Diluted EPS (TTM)
2.26
23.36%
Is it growing?
4.90%
22.40%
Is it risky?
0.52
115.13
2.37B
1.26
Who owns it?
32.15%
46.80%
0.00%
203.43M
107.50M
Does it pay?
2.80%
57.65%
May 18, 2026
--
How much cash?
380.47M
534.98M
536.78M
1.87
- Price (EOD)
- 51.30
- Percent Change
- +0.15 (0.29%)
- Previous Close
- 51.15
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€51.30
From 52W Low
--
From 52W High
--
Today
+0.29%
1Y Change
--
Today
€51.30
From 52W Low
--
From 52W High
--
Today
+0.29%
1Y Change
--
Today
€51.30
Fairly Priced
within its 1-year price range
€51.30
Rate of Change (ROC)
Insufficient price history
- Name
- Recordati Industria Chimica e Farmaceutica S.p.A.
- Founded
- 1926
- CEO
- Robert Koremans
- Employees
- 4,700
- Fiscal Year End
- Dec 31, 2025
- Address
Via Matteo Civitali,1
Milan
MI
20148
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- recordati.com
Related Heatmaps
FTSE MIBIndex FTSE MIB - FTSEMIB |